Inside Duke Medicine
Duke research improves treatment for Hepatitis C patients
posted February 22nd, 2010Duke researchers have pinpointed an enzyme deficiency protects Hepatitis C patients from treatment-related anemia.
The discovery opens the door to treatment for patients who had never been considered candidates for therapy before. It may also hold the key to new drugs that could prevent anemia from developing in the first place.
In this video, collaborators John McHutchison and David Goldstein discuss the findings.
Read more in this news release.